Fungal Susceptibility Testing
Blood Sample
Free Home Collection
Digital Smart Report
Recommended for Male/Female
NABL & CAP Certified Labs
Trusted by Leading Doctors & Organizations
About Fungal Susceptibility Testing
Fungal infections can be challenging to treat due to the increasing resistance of fungi to antifungal medications. Fungal Susceptibility Testing is a laboratory procedure used to determine the effectiveness of antifungal drugs against specific fungal strains. This test helps guide treatment decisions, ensuring that the most effective medication is prescribed for fungal infections. It is particularly essential for immunocompromised individuals, such as patients undergoing chemotherapy, organ transplants, or those with HIV/AIDS, as fungal infections can be life-threatening in such cases.
What is the Fungal Susceptibility Test Used For?
This test is used to:
- Identify the susceptibility of fungal pathogens to antifungal medications.
- Guide the selection of appropriate antifungal treatment based on laboratory findings.
- Monitor resistance patterns in fungal infections, helping to track emerging antifungal resistance.
- Support treatment decisions in immunocompromised patients who are at higher risk of severe fungal infections.
- Aid in the management of persistent or recurrent fungal infections that are unresponsive to standard treatments.
Symptoms Indicating the Need for the Test
Preparation for the test
No special preparation is required for this test. Patients should inform their doctor about any ongoing antifungal treatments, as they may affect test results. The type of sample required depends on the suspected infection site, which may include blood, urine, respiratory secretions, cerebrospinal fluid (CSF), tissue biopsies, or skin scrapings. In some cases, fasting or additional sample collection techniques may be required, depending on the physician’s recommendations.
Interpretation of Results
Interpretation of Results
- Susceptible (S): The fungus is likely to respond to the antifungal drug, and the treatment is expected to be effective.
- Intermediate (I): The drug may be effective at higher doses or under specific conditions but may not be the best option.
- Resistant (R): The fungus is unlikely to respond to the antifungal medication, necessitating alternative treatments.
Additional tests and clinical correlation with patient history and symptoms may be needed for a comprehensive treatment plan.
FAQs on Fungal Susceptibility Testing
A sample is obtained from the infected site, such as blood, urine, sputum, cerebrospinal fluid (CSF), or tissue, and analyzed in a laboratory.
Yes, ongoing antifungal treatments may impact the accuracy of susceptibility testing. Patients should inform their healthcare provider about any antifungal medications they are taking before the test.
Results typically take 2 to 7 days, depending on the fungal species and testing method used. Some specialized tests may take longer, especially for slow-growing fungal organisms.
Fungal resistance limits treatment options and can lead to persistent or severe infections, particularly in immunocompromised patients. Monitoring resistance helps in choosing the most effective antifungal therapy.
Yes, there are different types of susceptibility tests, including broth microdilution, disk diffusion, and gradient strip tests. The method used depends on the fungal species and the antifungal agent being tested.
Persistent or recurrent fungal infections despite antifungal treatment
Severe systemic fungal infections affecting vital organs such as the lungs, bloodstream, or brain
Opportunistic fungal infections in immunocompromised individuals, such as those with HIV/AIDS or undergoing chemotherapy
Unexplained skin rashes, nail discoloration, or chronic athlete’s foot
Symptoms such as fever, fatigue, weight loss, or respiratory distress that may be linked to invasive fungal infections

